Get the Stockscreener App
6.89
0.43%
-0.03
After Hours:
6.89
Kamada Ltd stock is traded at $6.89, with a volume of 81,521.
It is down -0.43% in the last 24 hours and up +1.03% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$6.92
Open:
$6.95
24h Volume:
81,521
Relative Volume:
1.36
Market Cap:
$397.93M
Revenue:
$154.57M
Net Income/Loss:
$15.07M
P/E Ratio:
25.52
EPS:
0.27
Net Cash Flow:
$10.92M
1W Performance:
-1.99%
1M Performance:
+1.03%
6M Performance:
+3.45%
1Y Performance:
+16.39%
1-Day Range:
$6.83
$6.9865
1-Week Range:
$6.82
$7.1065
52-Week Range:
$5.54
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
6.89 | 397.93M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Using Ichimoku Cloud for Kamada Ltd. technicalsEarnings Trend Report & High Conviction Investment Ideas - newser.com
Is Kamada Ltd. stock attractive after correctionJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com
Kamada (NASDAQ: KMDA) to announce Q3 results Nov 10; nine-month update to be discussed - Stock Titan
Is Kamada Ltd. stock in correction or buying zone2025 Support & Resistance & Growth Focused Investment Plans - newser.com
How supply chain issues affect Kamada Ltd. stockJuly 2025 Institutional & Verified Short-Term Plans - newser.com
Using flow based indicators on Kamada Ltd.Quarterly Risk Review & Real-Time Volume Trigger Notifications - newser.com
How Kamada Ltd. stock compares to growth peersShare Buyback & Free Verified High Yield Trade Plans - newser.com
Risk adjusted return profile for Kamada Ltd. analyzedJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
What’s next for Kamada Ltd. stock priceWeekly Stock Report & Safe Swing Trade Setups - newser.com
Price action breakdown for Kamada Ltd.Product Launch & Fast Exit/Entry Strategy Plans - newser.com
How Kamada Ltd. stock trades during market volatility2025 Key Highlights & Weekly High Return Stock Opportunities - newser.com
Published on: 2025-11-02 01:04:40 - newser.com
Does Kamada Ltd. show high probability of reboundQuarterly Earnings Summary & Verified Swing Trading Watchlist - newser.com
Kamada (NASDAQ:KMDA) Stock Passes Below 200-Day Moving AverageWhat's Next? - MarketBeat
How Kamada Ltd. stock performs in stagflation2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
Kamada to Present at the Stifel 2025 Healthcare Conference - The Manila Times
Kamada (NASDAQ: KMDA) Nov 12, 9:20 a.m. presentation Stifel Healthcare Conference; webcast - Stock Titan
Why Kamada Ltd. stock is in analyst buy zone2025 Risk Factors & Expert Approved Momentum Ideas - newser.com
Risk Recap: Is Kamada Ltd. stock a buy for dividend growthBear Alert & AI Driven Price Forecasts - fcp.pa.gov.br
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):